Evaluation of a Multicomponent Nature-based Intervention for Well-being and Relationship With Nature

December 16, 2024 updated by: Hospital Israelita Albert Einstein

Evaluation of the Effectiveness of a Multicomponent Nature-based Intervention for Well-being and Relationship With Nature in Different Natural Areas: a Randomized Clinical Trial

Randomized clinical trial to evaluate the efficacy of a multi-component nature-based intervention on clinical outcomes for visitors from different natural areas in Brazil.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

There is a growing scientific literature that indicates a series of benefits of contact/connection with nature for health and well-being, such as the mental health improvement, hypertension improvement, restoration of attention and memory and immune system improvement. It is already known, among other findings, that contact with nature, even indirectly, through videos and photos, can promote a greater sense of relaxation, decrease stress levels and can promote positive emotions. The adoption of nature-based interventions has been expanded, both for the prevention of chronic health conditions and the promotion of general well-being, as well as for the treatment of physical, mental and social health.

This clinical trial aims to assess the mean change in the World Health Organization well-being index, changes in self-perception of happiness, vitality, connection and engagement with nature in the pre-intervention, post-intervention and 30-day follow-up moments, in the control and intervention groups, in six different natural areas. In the multicomponent intervention, in addition to including walking in nature with attention to the senses, which will be carried out by the control group, the investigators associate other elements of a cognitive-behavioral nature, aiming human and non-human well-being. Therefore, in this health nature-based intervention, activities related to four types of experience are proposed (1- knowledge; 2- aesthetic/emotional; 3- integrated multisensory, 4- active experience). The study hypothesis is that Well-being, happiness and vitality outcomes will be more positive in the intervention group, and the connection with nature and engagement with conservation at 30 days post-intervention will be greater in the intervention group as well, due to adherence to nature-related activities that will be monitored and knowledge offered

Study Type

Interventional

Enrollment (Actual)

486

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • São Paulo, Brazil, 02377-000
        • Parque Estadual da Cantareira
    • PR
      • Guaraqueçaba, PR, Brazil, 83390-000
        • Reserva Particular de Patrimônio Natural Salto Morato
    • SP
      • Bertioga, SP, Brazil, 11250-000
        • Parque das Neblinas
      • Sao Paulo, SP, Brazil, 05503-900
        • Instituto butantan
      • São Paulo, SP, Brazil, 04858-570
        • Parque Natural Municipal Varginha
      • São Paulo, SP, Brazil, 08265-060
        • Parque Natural Municipal Fazenda do Carmo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Voluntary participation;
  • Signed in the Informed Consent Form (able to understand and agree to participate in the study)
  • Have conditions of digital access to the link of the study questionnaires, which will be provided by the team.

Exclusion Criteria:

  • Display walking difficulties;
  • Participants with phobia related to elements of nature;
  • History of allergies when in contact with nature.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention A Time with e-Nature Group (Multicomponent Nature-Based Intervention - MNBI)
After signing the Free and Informed Consent Term, participants will be directed to a multicomponent intervention based on the experience of aesthetic, emotional and multisensory appreciation, knowledge, environmental education/interpretation and active involvement. At the end of the activity, the participants will fill in the post-intervention questionnaires, which will be applied immediately and 30 days after the intervention.

Integrated multisensory experience (aesthetic, emotional and knowledge) in two stages:

  1. Observation of nature through the senses (smell, hearing, sight, touch, taste) and the appreciative look.
  2. Observation focused on the local avifauna and flora during the trail accompanied by a research biologist from the group.
Active Comparator: Control Group
The group will do an activity made up of contact with nature during a light walk with attention directed to the senses (classical forest bathing). The trail will be accompanied by a guide who will not make any type of intervention other than offering the questionnaires to be filled in at the end of the activity and driving in the section foreseen for the activity.

Integrated multisensory experience (aesthetic, emotional and knowledge) in two stages:

  1. Observation of nature through the senses (smell, hearing, sight, touch, taste) and the appreciative look.
  2. Observation focused on the local avifauna and flora during the trail accompanied by a research biologist from the group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline Well-Being Index at 30 days follow-up.
Time Frame: immediately pre and immediately post intervention and within 4 weeks post intervention
The World Health Organization-5 Well-Being Index is a brief scale, composed of five questions in which the participants indicate in each one of them, based on the last two weeks, the frequency of their sensations, being 0 (at no time) and 5 (all of the time). The result is given as the sum of the numbers of each statement, with values ranging from 0, which represents the worst possible quality of life and 25, which is associated with the best possible quality of life.
immediately pre and immediately post intervention and within 4 weeks post intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline self-perception of happiness at immediate post-intervention and 30 days follow-up.
Time Frame: immediately pre and immediately post intervention and within 4 weeks post intervention
A single question about ): "generally feel happy?" with an 11-point response scale (0-10) for providing a reliable and valid measure of well-being for community surveys. It is a numerical scale that varies from and used in various research ranging from 0 (extremely unhappy) to 10 (extremely happy). There is no founder of this scale being used freely as a numerical scale for several variables in which the individual can quantify in some way what is being studied. The score ranges from 0 to 10. The higher the score, the greater the happiness.
immediately pre and immediately post intervention and within 4 weeks post intervention
Change from baseline vitality at immediate post-intervention and 30 days follow-up.
Time Frame: immediately pre and immediately post intervention and within 4 weeks post intervention
Subjective Vitality Scale consists of seven items answered on a seven-point scale, ranging from 1 (not at all true) to 7 (completely true). The respondent needs to indicate how true what the item expresses about how he is currently feeling is true.The participant needs to indicate how true what the item expresses about how they are currently feeling is true. The score ranges from 7 to 49. The higher the score, the greater vitality.
immediately pre and immediately post intervention and within 4 weeks post intervention
Change of Connection with Nature from baseline to 30 days post-intervention
Time Frame: Immediately Pre intervention and within 4 weeks post intervention
The Nature Connection Scale (NCS) is used to verify the affective aspect of the person-environment relationship. It is composed of 14 items that are answered on a Likert Scale of points, ranging from 1 (I totally disagree) to 5 (I totally agree). The score ranges from 14 to 70. The higher the score, the greater the connection with nature.
Immediately Pre intervention and within 4 weeks post intervention
Change from baseline nature engagement at 30 days after intervention
Time Frame: Immediately Pre intervention and within 4 weeks post intervention

Nature engagement questions was developed by the project researchers themselves, with variables that trace the main motivations of the participants to go to nature, as well as variables related to the population's engagement with nature.

In this way, it will be used to assess the frequency, motivation and access to natural areas, as well as the engagement of participants in three dimensions (values, actions taken at home in favor of nature and nature conservation actions).These questions allow to calculate the percentage of engagement for each type of action.The higher the percentage, the higher the engagement.

Immediately Pre intervention and within 4 weeks post intervention

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perception at the end of nature-based experience
Time Frame: Immediately Post intervention
The participants emit the perception of the experience in a single word.
Immediately Post intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Eliseth R Leão, PhD, Hospital Israelita Albert Einstein
  • Study Chair: Roberta M Savieto, MNP, Hospital Israelita Albert Einstein
  • Study Chair: Denise TN Maki, MD, Hospital Israelita Albert Einstein
  • Study Chair: Letícia B Oliveira, BSN, Hospital Israelita Albert Einstein
  • Study Chair: Luccas GR Longo, MSc, São Paulo Municipal Secretary of Green and the Environment
  • Study Chair: Luciano M Lima, MSc, Butantan Institute
  • Study Chair: Erika Hingst-Zaher, Phd, Butantan Institute
  • Study Chair: Karina P Patricio, PhD, The Medical School (FMB) of São Paulo State University (Unesp),
  • Study Chair: Gustavo Borba, PhD, The Federal University of Technology - Paraná
  • Study Chair: Lital Bass, BSN, Hospital Israelita Albert Einstein
  • Study Chair: Sabrina Bomfim, Hospital Israelita Albert Einstein
  • Study Chair: Floriana Bertini, MD, Hospital Israelita Albert Einstein

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 8, 2022

Primary Completion (Actual)

May 1, 2023

Study Completion (Actual)

June 24, 2023

Study Registration Dates

First Submitted

July 26, 2022

First Submitted That Met QC Criteria

August 1, 2022

First Posted (Actual)

August 3, 2022

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 16, 2024

Last Verified

August 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Well-being

Clinical Trials on A Time with e-Nature

Subscribe